Dive into Recursion's innovative approach to decoding biology. Join our mission, explore the future of TechBio, and be part of the revolution.
People also ask
What is recursion pharmaceutical?
Is Recursion Pharmaceuticals a good stock to buy?
Is Recursion a good company?
How many employees does recursion pharma have?
Overview Biotechnology / Healthcare. Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery.
CEO: Christopher Gibson (Nov 2013–)
Founders: Christopher Gibson, Blake Borgeson, and Dean Li
Headquarters: Salt Lake City, UT
Date founded: 2013
Location: Salt Lake City, Utah
Show more
Show less
Jul 26, 2024 · We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company.
Recursion Pharmaceuticals is creating an AI-enabled human biology map to accelerate discovery of treatments for rare, untreated diseases.
Aug 19, 2024 · Recursion will release proof-of-concept clinical trial data over the next 12 months; investor interest in seeing if AI can speed drug ...
Recursion Pharma, a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, ...
Sep 3, 2024 · Recursion Pharmaceuticals on Tuesday said results from a mid-stage trial showed its lead experimental drug to be safe, the first readout in a ...
People also search for